Items where the Funder is GlaxoSmithKline
Number of items: 5.
  • Real-world effectiveness and adverse events caused by ACE inhibitors and ARBs for reduction in cardiovascular events with validation against the ONTARGET trial. (2023) Baptiste, PJ
  • Application of methods for handling unmeasured confounding in pharmacoepidemiological studies. (2023) Brown, JP
  • Prescribing trends, utilisation and comparative effectiveness of antidiabetic drug therapies prescribed in UK primary care. (2020) Wilkinson, S
  • Asthma in electronic health records: validity and phenotyping. (2019) Nissen, FW
  • Pharmacoepidemiology of autoimmune diseases. (2007) Schoonen, WM